MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-17-2024
ThermoGenesis Holdings Retained Earnings 2011-2026 | THMO
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings ThermoGenesis Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -266 M | -265 M | -253 M | -237 M | -227 M | -185 M | -156 M | -138 M | -123 M | -114 M | -111 M | -106 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -106 M | -266 M | -182 M |
Quarterly Retained Earnings ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -286 M | -284 M | -277 M | -274 M | -271 M | -266 M | -263 M | -260 M | -257 M | -265 M | -262 M | -260 M | -256 M | -253 M | -253 M | -253 M | -253 M | -237 M | -237 M | -237 M | -237 M | -227 M | -227 M | -227 M | -227 M | -188 M | -188 M | -188 M | -188 M | -182 M | -179 M | -156 M | -156 M | -142 M | -141 M | -138 M | -138 M | -130 M | -126 M | -123 M | -123 M | -118 M | -116 M | -114 M | -114 M | -111 M | -110 M | -111 M | -111 M | -109 M | -107 M | -106 M | -106 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -106 M | -286 M | -192 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.2 | 2.8 % | $ 3.43 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 10.54 | 1.15 % | $ 1.42 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.34 | -0.48 % | $ 599 M |  Israel |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.92 | -1.31 % | $ 1.15 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.18 | 7.03 % | $ 885 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 12.78 | 1.43 % | $ 1.92 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.69 | 6.49 % | $ 37.6 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.06 | 2.53 % | $ 151 M |  France |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 71.7 | 2.74 % | $ 106 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-496 M | $ 64.81 | 2.09 % | $ 1.92 B |  Costa-rica |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 11.17 | 1.27 % | $ 302 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.32 | -0.6 % | $ 21.3 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.44 | 0.11 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.21 | 0.68 % | $ 1.34 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.51 | 0.6 % | $ 873 M | Israel |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 62.56 | 1.83 % | $ 3.41 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 4.46 | 1.02 % | $ 659 M | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 111.38 | 1.3 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.83 | 0.2 % | $ 352 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 268.98 | 2.96 % | $ 7.59 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.58 | -0.39 % | $ 151 M | Israel |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.16 | 1.66 % | $ 705 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 32.81 | -0.09 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 176.6 | 4.22 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 33.72 | 2.93 % | $ 5.02 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-89.1 M | $ 3.78 | 2.86 % | $ 155 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.15 | 0.23 % | $ 402 M | USA |